Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses
The chronological differentiation of the urovaginal septum of the female rat fetus and its critical period for the virilizing activity of testosterone were examined by measuring the urovagival septum length directly under microscope equipped with a micrometer. Until the 18th day of gestation, defini...
Gespeichert in:
Veröffentlicht in: | Endocrinologia Japonica 1977, Vol.24(1), pp.67-70 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 70 |
---|---|
container_issue | 1 |
container_start_page | 67 |
container_title | Endocrinologia Japonica |
container_volume | 24 |
creator | KAWASHIMA, KUNIO NAKAURA, SHINSUKE NAGAO, SHIGEYUKI TANAKA, SATORU KUWAMURA, TSUKASA OMORI, YOSHIHITO |
description | The chronological differentiation of the urovaginal septum of the female rat fetus and its critical period for the virilizing activity of testosterone were examined by measuring the urovagival septum length directly under microscope equipped with a micrometer. Until the 18th day of gestation, definite differentiation of the urovaginal septum was not observed, but thereafter the septum developed rapidly and on the 21st day it was built up almost completely to separate the urethra and vagina. Following a consecutive maternal subcutaneous administration of various doses of testosterone in olive oil for 4 days between the 17th and 20th day of gestation, a significant abridgment in urovaginal septum length was noted at a dose level of 0.01 mg/rat. In the chronological examination, a significant inhibition of urovaginal septum development was observed 3 days after a single dose of 5 mg/rat of testosterone on the 17th day of gestation. When the same dose of testosterone was given on the 16th day of gestation, no effect was observed in the urovaginal septum length of female fetus on the 21st day of gestation. In the 17th-day-treatment group, however, a highly significant abridgment in the urovaginal septum was noticed compared with the control. Further abridgment was observed in the 18th day treatment group, and the 19th-day-treatment group showed the largest abridgment, but the length change in the 20th-day-treatment group was comparable to that in the 17th-day-treatment group. On these findings, it was concluded that the critical day of urovaginal septum abridgment by the virilizing activity of exogenous testosterone appeared to be the 19th day of gestation in female rat fetuses. |
doi_str_mv | 10.1507/endocrj1954.24.67 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_83949587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>83949587</sourcerecordid><originalsourceid>FETCH-LOGICAL-c549t-2334472e1b7ae6c37be5b5090ec4c395b6b24feac3962c406649784abe7b8f103</originalsourceid><addsrcrecordid>eNpdkE9r3DAQxUVJmyxpPkAhB51y81b_ZR_DNtsGAi1tcjaSPN5qsa2tJBfy7aPFYQnRYTTM-81jeAh9oWRNJdFfYeqCi3vaSLFmYq30B7RitJaV4pqcoRUhlFea0eYCXaW0J-UpprQg5-iTlHWt6xU6fPN9DxGm7E32YcKhx08x_Dc7P5kB_4FDnkdspg77nPAm-uxdmf-C6EN3hG9t9N1uLAbYPuNHSDmkDDFMgP2EtzCaAfBvk0ub5wTpM_rYmyHB1et_iZ62d4-bH9XDz-_3m9uHyknR5IpxLoRmQK02oBzXFqSVpCHghOONtMoy0YMpvWJOEKVEo2thLGhb95TwS3Sz-B5i-DeXs9rRJwfDYCYIc2pr3ohG1rqAdAFdDClF6NtD9KOJzy0l7THn9k3OLROtOu5cv5rPdoTutLGkWuTtIu9TNjs4ySaW9AZ4b0iXovQJcH9NLBR_AWKolMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83949587</pqid></control><display><type>article</type><title>Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><creator>KAWASHIMA, KUNIO ; NAKAURA, SHINSUKE ; NAGAO, SHIGEYUKI ; TANAKA, SATORU ; KUWAMURA, TSUKASA ; OMORI, YOSHIHITO</creator><creatorcontrib>KAWASHIMA, KUNIO ; NAKAURA, SHINSUKE ; NAGAO, SHIGEYUKI ; TANAKA, SATORU ; KUWAMURA, TSUKASA ; OMORI, YOSHIHITO</creatorcontrib><description>The chronological differentiation of the urovaginal septum of the female rat fetus and its critical period for the virilizing activity of testosterone were examined by measuring the urovagival septum length directly under microscope equipped with a micrometer. Until the 18th day of gestation, definite differentiation of the urovaginal septum was not observed, but thereafter the septum developed rapidly and on the 21st day it was built up almost completely to separate the urethra and vagina. Following a consecutive maternal subcutaneous administration of various doses of testosterone in olive oil for 4 days between the 17th and 20th day of gestation, a significant abridgment in urovaginal septum length was noted at a dose level of 0.01 mg/rat. In the chronological examination, a significant inhibition of urovaginal septum development was observed 3 days after a single dose of 5 mg/rat of testosterone on the 17th day of gestation. When the same dose of testosterone was given on the 16th day of gestation, no effect was observed in the urovaginal septum length of female fetus on the 21st day of gestation. In the 17th-day-treatment group, however, a highly significant abridgment in the urovaginal septum was noticed compared with the control. Further abridgment was observed in the 18th day treatment group, and the 19th-day-treatment group showed the largest abridgment, but the length change in the 20th-day-treatment group was comparable to that in the 17th-day-treatment group. On these findings, it was concluded that the critical day of urovaginal septum abridgment by the virilizing activity of exogenous testosterone appeared to be the 19th day of gestation in female rat fetuses.</description><identifier>ISSN: 0013-7219</identifier><identifier>EISSN: 2185-6370</identifier><identifier>DOI: 10.1507/endocrj1954.24.67</identifier><identifier>PMID: 558878</identifier><language>eng</language><publisher>Japan: The Japan Endocrine Society</publisher><subject>Animals ; Female ; Fetus ; Gestational Age ; Male ; Morphogenesis - drug effects ; Pregnancy ; Rats ; Testosterone - pharmacology ; Urethra - embryology ; Vagina - embryology</subject><ispartof>Endocrinologia Japonica, 1977, Vol.24(1), pp.67-70</ispartof><rights>The Japan Endocrine Society</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c549t-2334472e1b7ae6c37be5b5090ec4c395b6b24feac3962c406649784abe7b8f103</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1876,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/558878$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAWASHIMA, KUNIO</creatorcontrib><creatorcontrib>NAKAURA, SHINSUKE</creatorcontrib><creatorcontrib>NAGAO, SHIGEYUKI</creatorcontrib><creatorcontrib>TANAKA, SATORU</creatorcontrib><creatorcontrib>KUWAMURA, TSUKASA</creatorcontrib><creatorcontrib>OMORI, YOSHIHITO</creatorcontrib><title>Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses</title><title>Endocrinologia Japonica</title><addtitle>Endocrinol Japon</addtitle><description>The chronological differentiation of the urovaginal septum of the female rat fetus and its critical period for the virilizing activity of testosterone were examined by measuring the urovagival septum length directly under microscope equipped with a micrometer. Until the 18th day of gestation, definite differentiation of the urovaginal septum was not observed, but thereafter the septum developed rapidly and on the 21st day it was built up almost completely to separate the urethra and vagina. Following a consecutive maternal subcutaneous administration of various doses of testosterone in olive oil for 4 days between the 17th and 20th day of gestation, a significant abridgment in urovaginal septum length was noted at a dose level of 0.01 mg/rat. In the chronological examination, a significant inhibition of urovaginal septum development was observed 3 days after a single dose of 5 mg/rat of testosterone on the 17th day of gestation. When the same dose of testosterone was given on the 16th day of gestation, no effect was observed in the urovaginal septum length of female fetus on the 21st day of gestation. In the 17th-day-treatment group, however, a highly significant abridgment in the urovaginal septum was noticed compared with the control. Further abridgment was observed in the 18th day treatment group, and the 19th-day-treatment group showed the largest abridgment, but the length change in the 20th-day-treatment group was comparable to that in the 17th-day-treatment group. On these findings, it was concluded that the critical day of urovaginal septum abridgment by the virilizing activity of exogenous testosterone appeared to be the 19th day of gestation in female rat fetuses.</description><subject>Animals</subject><subject>Female</subject><subject>Fetus</subject><subject>Gestational Age</subject><subject>Male</subject><subject>Morphogenesis - drug effects</subject><subject>Pregnancy</subject><subject>Rats</subject><subject>Testosterone - pharmacology</subject><subject>Urethra - embryology</subject><subject>Vagina - embryology</subject><issn>0013-7219</issn><issn>2185-6370</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1977</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkE9r3DAQxUVJmyxpPkAhB51y81b_ZR_DNtsGAi1tcjaSPN5qsa2tJBfy7aPFYQnRYTTM-81jeAh9oWRNJdFfYeqCi3vaSLFmYq30B7RitJaV4pqcoRUhlFea0eYCXaW0J-UpprQg5-iTlHWt6xU6fPN9DxGm7E32YcKhx08x_Dc7P5kB_4FDnkdspg77nPAm-uxdmf-C6EN3hG9t9N1uLAbYPuNHSDmkDDFMgP2EtzCaAfBvk0ub5wTpM_rYmyHB1et_iZ62d4-bH9XDz-_3m9uHyknR5IpxLoRmQK02oBzXFqSVpCHghOONtMoy0YMpvWJOEKVEo2thLGhb95TwS3Sz-B5i-DeXs9rRJwfDYCYIc2pr3ohG1rqAdAFdDClF6NtD9KOJzy0l7THn9k3OLROtOu5cv5rPdoTutLGkWuTtIu9TNjs4ySaW9AZ4b0iXovQJcH9NLBR_AWKolMA</recordid><startdate>19770101</startdate><enddate>19770101</enddate><creator>KAWASHIMA, KUNIO</creator><creator>NAKAURA, SHINSUKE</creator><creator>NAGAO, SHIGEYUKI</creator><creator>TANAKA, SATORU</creator><creator>KUWAMURA, TSUKASA</creator><creator>OMORI, YOSHIHITO</creator><general>The Japan Endocrine Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19770101</creationdate><title>Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses</title><author>KAWASHIMA, KUNIO ; NAKAURA, SHINSUKE ; NAGAO, SHIGEYUKI ; TANAKA, SATORU ; KUWAMURA, TSUKASA ; OMORI, YOSHIHITO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c549t-2334472e1b7ae6c37be5b5090ec4c395b6b24feac3962c406649784abe7b8f103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1977</creationdate><topic>Animals</topic><topic>Female</topic><topic>Fetus</topic><topic>Gestational Age</topic><topic>Male</topic><topic>Morphogenesis - drug effects</topic><topic>Pregnancy</topic><topic>Rats</topic><topic>Testosterone - pharmacology</topic><topic>Urethra - embryology</topic><topic>Vagina - embryology</topic><toplevel>online_resources</toplevel><creatorcontrib>KAWASHIMA, KUNIO</creatorcontrib><creatorcontrib>NAKAURA, SHINSUKE</creatorcontrib><creatorcontrib>NAGAO, SHIGEYUKI</creatorcontrib><creatorcontrib>TANAKA, SATORU</creatorcontrib><creatorcontrib>KUWAMURA, TSUKASA</creatorcontrib><creatorcontrib>OMORI, YOSHIHITO</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrinologia Japonica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAWASHIMA, KUNIO</au><au>NAKAURA, SHINSUKE</au><au>NAGAO, SHIGEYUKI</au><au>TANAKA, SATORU</au><au>KUWAMURA, TSUKASA</au><au>OMORI, YOSHIHITO</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses</atitle><jtitle>Endocrinologia Japonica</jtitle><addtitle>Endocrinol Japon</addtitle><date>1977-01-01</date><risdate>1977</risdate><volume>24</volume><issue>1</issue><spage>67</spage><epage>70</epage><pages>67-70</pages><issn>0013-7219</issn><eissn>2185-6370</eissn><abstract>The chronological differentiation of the urovaginal septum of the female rat fetus and its critical period for the virilizing activity of testosterone were examined by measuring the urovagival septum length directly under microscope equipped with a micrometer. Until the 18th day of gestation, definite differentiation of the urovaginal septum was not observed, but thereafter the septum developed rapidly and on the 21st day it was built up almost completely to separate the urethra and vagina. Following a consecutive maternal subcutaneous administration of various doses of testosterone in olive oil for 4 days between the 17th and 20th day of gestation, a significant abridgment in urovaginal septum length was noted at a dose level of 0.01 mg/rat. In the chronological examination, a significant inhibition of urovaginal septum development was observed 3 days after a single dose of 5 mg/rat of testosterone on the 17th day of gestation. When the same dose of testosterone was given on the 16th day of gestation, no effect was observed in the urovaginal septum length of female fetus on the 21st day of gestation. In the 17th-day-treatment group, however, a highly significant abridgment in the urovaginal septum was noticed compared with the control. Further abridgment was observed in the 18th day treatment group, and the 19th-day-treatment group showed the largest abridgment, but the length change in the 20th-day-treatment group was comparable to that in the 17th-day-treatment group. On these findings, it was concluded that the critical day of urovaginal septum abridgment by the virilizing activity of exogenous testosterone appeared to be the 19th day of gestation in female rat fetuses.</abstract><cop>Japan</cop><pub>The Japan Endocrine Society</pub><pmid>558878</pmid><doi>10.1507/endocrj1954.24.67</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-7219 |
ispartof | Endocrinologia Japonica, 1977, Vol.24(1), pp.67-70 |
issn | 0013-7219 2185-6370 |
language | eng |
recordid | cdi_proquest_miscellaneous_83949587 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese |
subjects | Animals Female Fetus Gestational Age Male Morphogenesis - drug effects Pregnancy Rats Testosterone - pharmacology Urethra - embryology Vagina - embryology |
title | Differentiation of Urovaginal Septum and its Critical Period of Abridgment by Testosterone in Female Rat Fetuses |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T10%3A00%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20of%20Urovaginal%20Septum%20and%20its%20Critical%20Period%20of%20Abridgment%20by%20Testosterone%20in%20Female%20Rat%20Fetuses&rft.jtitle=Endocrinologia%20Japonica&rft.au=KAWASHIMA,%20KUNIO&rft.date=1977-01-01&rft.volume=24&rft.issue=1&rft.spage=67&rft.epage=70&rft.pages=67-70&rft.issn=0013-7219&rft.eissn=2185-6370&rft_id=info:doi/10.1507/endocrj1954.24.67&rft_dat=%3Cproquest_cross%3E83949587%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83949587&rft_id=info:pmid/558878&rfr_iscdi=true |